February 01, 2015 5:16 PM ET


Company Overview of Danube Pharmaceuticals, Inc.

Executive Profile

L. Jay Katz M.D., FACS

Member of Scientific Advisory Board, Inotek Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships


Mr. L. Jay Katz, M.D., FACS serves as Professor of Ophthalmology at Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. Mr. Katz serves as a Director of the Glaucoma Service, Wills Eye Hospital. He serves as Member of the Scientific Advisory Board of Danube Pharmaceuticals, Inc., Inotek Pharmaceuticals Corporation and Glaukos Corporation. Dr. Katz has published more than 120 articles in journals such as Archives of Ophthalmology, the American ...

Corporate Headquarters

689 Fifth Avenue
New York, New York 10022

United States

Phone: 646-375-4641
Fax: 646-375-4651

Board Members Memberships

There is no Board Members Memberships data available.


Unknown/Other Education
Yale University
Unknown/Other Education
University of Virginia
Yale University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Danube Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.